The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Torisel
temsirolimus · Kit · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
NDC 00008-1179-01 · 1 KIT in 1 CARTON * 25 mL in 1 VIAL, SINGLE-USE * 1.8 mL in 1 VIAL, SINGLE-USE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$32.68per billing unit (1 MG)HCPCS J9330 · Jul 1, 2026
- Federal ceiling (Big4)$1,497.33per package of 1.8MLPfizer Inc. · Jan 1, 2026
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$2,000.32
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$32.681
HCPCS J9330 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2023)
$12,491
22 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · api manufacture
- analysis
- analysis
- Wyeth Lederle SRLItalyanalysis · label
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA022088
- TE code
- AP
- Approval date
- May 30, 2007
- Patents / exclusivity
- 4 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8791097*PED | Nov 10, 2032 |
| patent | 8791097 | May 10, 2032 |
| patent | 8026276*PED | Jul 20, 2026 |
| patent | 8026276 | Jan 20, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class III · TerminatedOct 10, 2014Pfizer Inc. — Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.
- Class III · TerminatedNov 26, 2012Pfizer Inc. — Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.
Manufacturers of temsirolimus (Kit)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Accord Healthcare Inc. | Jul 15, 2026 | Sep 2, 2026 | |
| Fresenius Kabi USA, LLC | Jul 15, 2026 | Sep 2, 2026 | |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Torisel — NDC 00008-1179-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00008117901.
Free to cite with attribution — see how the data is put together.